Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy.

Chan, Joyce J T; Lam, Carol P S; Kwok, Madeline K M; Wong, Raymond L M; Lee, Gary K Y; Lau, Winnie W Y; Yam, Jason C S

Chan, Joyce J T; Lam, Carol P S; Kwok, Madeline K M; Wong, Raymond L M; Lee, Gary K Y; Lau, Winnie W Y; Yam, Jason C S.

Affiliation

Chan JJT; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Lam CPS; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Kwok MKM; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Wong RLM; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Lee GKY; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Lau WWY; Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.
Yam JCS; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, 147K, Argyle Street, Kowloon City, Kowloon, Hong Kong SAR.

Sci Rep ; 6: 27082, 2016 06 01.

Article de En | MEDLINE | ID: mdl-27256987

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rétine / Rétinopathie du prématuré / Inhibiteurs de l'angiogenèse / Thérapie laser / Ranibizumab Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies Limites: Female / Humans / Infant / Male / Newborn Langue: En Journal: Sci Rep Année: 2016 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google